Real‐world EGFR testing in patients with stage IIIB/IV non‐small‐cell lung cancer in North China: A multicenter, non‐interventional study

BACKGROUND: Before tyrosine kinase inhibitor (TKI) therapy can be administered in patients with advanced non‐small cell lung cancer (NSCLC), EGFR mutation testing is required. However, few studies have evaluated the extent of EGFR testing in real‐world practice in China. METHODS: A multicenter, obse...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Cheng, Ying, Wang, Yan, Zhao, Jun, Liu, Yunpeng, Gao, Hongjun, Ma, Kewei, Zhang, Shucai, Xin, Hua, Liu, Jiwei, Han, Chengbo, Zhu, Zhitu, Chen, Jun, Wen, Fugang, Li, Junling, Zhang, Jie, Zheng, Zhendong, Dai, Zhaoxia, Piao, Hongmei, Li, Xiaoling, Li, Yinyin, Zhong, Min, Ma, Rui, Zhuang, Yongzhi, Xu, Yuqing, Qu, Zhuohui, Yang, Haibo, Pan, Chunxia, Yang, Fan, Zhang, Daxin, Li, Bing
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6209800/
https://ncbi.nlm.nih.gov/pubmed/30253083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12859
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados